Skip to main content
. 2011 May 15;11(10):853–865. doi: 10.4161/cbt.11.10.15177

Figure 1.

Figure 1

Figure 1

Figure 1

Figure 1

Figure 1

Percent methylation* by ER, HER2, lymph node status, tumor stage and history of recurrent or metastatic disease. *Percent methylation is based on the log of percent methylation + 1 or log (% M + 1). Percent ERα (A), TWIST (B), CyclinD2 (C), CDH1 (D), AP C (E), RASS F1A (F), HIN1 (G), RARβ (H), BRCA1 (I), BRCA2 (J) methylation by ER, HER2, lymph node status, tumor stage and history of recurrent or metastatic disease.